Why the study?
Does anticoagulant therapy improve outcomes in patients with thrombophlebitis and pulmonary embolism?
Does anticoagulant therapy improve outcomes in patients with thrombophlebitis and pulmonary embolism?
This early review highlights the successful introduction of anticoagulant therapy for the treatment and prophylaxis of thrombophlebitis and pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Supports anticoagulant use in thrombophlebitis and PE; extends collective experience but leaves open randomized confirmation.
ExcerptTHE TREATMENT AND PROPHYLAXIS OF THROMBOPHLEBITIS AND PULMONARY EMBOLISMThe first group of diseases to be attacked by means of anticoagulant therapy was quite logically those loosely classified under the broad term of thrombophlebitis, which includes so-called "phlebothrombosis." That this attack has been remarkably successful, though not without some difficulties, is clearly demonstrated by the experiences reported from many workers in this country and abroad.The significance of this problem is established by the figures compiled by Jorpes from large clinics in widely scattered portions of the world (table 1) (quoted from Zilliacus1).Thus it is clearly shown that among...
No takes yet. Share an insight, caveat, or question.
I. S. Wright (1949) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: